Andorra vs France: Proportion of the target population who received a 3rd dose of
Andorra
96.0%
in 2024
France
96.0%
in 2024
Andorra rank
16th
France rank
16th
Proportion of the target population who received a 3rd dose of over time
- Andorra
- France
How they compare
Andorra currently reports 96.0% against 96.0% in France, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2014 it was Andorra ahead.
Andorra ranks 16th and France ranks 16th of 157 countries.
Across the 2 decades both report, Andorra averaged higher in 1 and France in 1.
Head to head by decade
| Decade | Andorra | France | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.2% | 91.5% | 2.7% | Andorra |
| 2020s | 95.2% | 95.6% | 0.4% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Andorra or France?
- Andorra, at 96.0% against 96.0% in France as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Andorra and France?
- 0.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and France?
- 11 years are reported by both, from 2014 to 2024.
- How do Andorra and France rank globally for proportion of the target population who received a 3rd dose of?
- Andorra ranks 16th and France ranks 16th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.